180 Life Sciences Corp (ATNF) Has A Promising Outlook For 2024

180 Life Sciences Corp (NASDAQ:ATNF) has seen 56.54 million shares traded in the recent trading session. The company, currently valued at $5.13M, closed the recent trade at $9.67 per share which meant it gained $8.15 on the day or 536.18% during that session. The ATNF stock price is -15.93% off its 52-week high price of $11.21 and 88.0% above the 52-week low of $1.16. If we look at the company’s 10-day average daily trading volume, we find that it stood at 79420.0 shares traded. The 3-month trading volume is 66.55K shares.

180 Life Sciences Corp (NASDAQ:ATNF) trade information

Sporting 536.18% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the ATNF stock price touched $9.67 or saw a rise of 45.52%. Year-to-date, 180 Life Sciences Corp shares have moved 138.38%, while the 5-day performance has seen it change 605.84%. Over the past 30 days, the shares of 180 Life Sciences Corp (NASDAQ:ATNF) have changed 385.93%. Short interest in the company has seen 73286.0 shares shorted with days to cover at 0.89.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

180 Life Sciences Corp (ATNF) estimates and forecasts

The company’s shares have gained 406.28% over the past 6 months.

ATNF Dividends

180 Life Sciences Corp is expected to release its next earnings report on 2022-Nov-10 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

180 Life Sciences Corp (NASDAQ:ATNF)’s Major holders

Insiders own 1.49% of the company shares, while shares held by institutions stand at 6.39% with a share float percentage of 6.49%. Investors are also buoyed by the number of investors in a company, with 180 Life Sciences Corp having a total of 9.0 institutions that hold shares in the company.

Also the top two Mutual Funds that are holding company’s shares are Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. As of Aug 31, 2024, the former fund manager holds about 0.46% shares in the company for having 4.74 shares of worth $46649.0 while later fund manager owns 2.52 shares of worth $24831.0 as of Jun 30, 2024, which makes it owner of about 0.25% of company’s outstanding stock.